Lehrstuhl für Geburtshilfe und Frauenheilkunde

Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial (2022) Graf J, Sickenberger N, Brusniak K, Matthies LM, Deutsch TM, Simoes E, Plappert C, et al. Journal article Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2− Advanced Breast Cancer in the MONALEESA-3 Trial (2022) Jerusalem G, Delea TE, Martin M, De Laurentiis M, Nusch A, Beck JT, Chan A, et al. Journal article Comparison of C-Reactive Protein in Dried Blood Spots and Saliva of Healthy Adolescents (2021) Plank AC, Maschke J, Rohleder N, Fasching P, Beckmann M, Kornhuber J, Eichler A, et al. Journal article Potential of spiral breast computed tomography to increase patient comfort compared to DM (2021) Wetzl M, Wenkel E, Dietzel M, Siegler L, Emons J, Dethlefsen E, Heindl F, et al. Journal article Prenatal Androgen Influence on Addictive Behaviour in Adolescence Vorgeburtlicher Androgen- einfluss auf süchtiges Verhalten in der Adoleszenz (2021) Lenz B, Eichler A, Buchholz VN, Fasching P, Kornhuber J Journal article, Review article Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program (2021) Müller V, Banys-Paluchowski M, Friedl TW, Fasching P, Schneeweiss A, Hartkopf A, Wallwiener D, et al. Journal article Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study (2021) Harbeck N, Rastogi P, Martin M, Tolaney SM, Shao ZM, Fasching P, Huang CS, et al. Journal article A careful reassessment of anthracycline use in curable breast cancer (2021) Hurvitz SA, Mcandrew NP, Bardia A, Press MF, Pegram M, Crown JP, Fasching P, et al. Journal article, Review article DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status (2021) Jurmeister P, Weber K, Villegas S, Karn T, Untch M, Thieme A, Mueller V, et al. Journal article Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer (BMC Cancer, (2021), 21, 1, (920), 10.1186/s12885-021-08656-0) (2021) Stuerken C, Moebus V, Milde-Langosch K, Schmatloch S, Fasching P, Rueschoff J, Stickeler E, et al. Journal article, Erratum